IDbyDNA

About:

IDbyDNA democratizes Precision Metagenomics to uncover the microbial world.

Website: http://idbydna.com/

Twitter/X: idbydnainc

Top Investors: ARUP Laboratories, Abstract Ventures, Horizon Technology Finance, Artis Ventures (AV), Sand Hill Angels

Description:

We passionately believe that infectious disease patients should be treated with the same precision that cancer patients receive today. As our population increases, our economies become more global, and we continue over-usage of broad-spectrum antibiotics, infectious diseases are going to continue to spread and become more pernicious. Our clinical practices must evolve with disease to become more precise in our diagnostic and treatment tools. At IDbyDNA, our goal is to accelerate these solutions and uncover the microbial world to reduce infectious disease-associated morbidity and mortality

Total Funding Amount:

$64M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Salt Lake City, Utah, United States

Founded Date:

2014-11-01

Founders:

Guochun Liao, Mark Yandell, Martin G. Reese, Robert Schlaberg

Number of Employees:

11-50

Last Funding Date:

2020-12-31

IPO Status:

Private

Industries:

© 2025 bioDAO.ai